Gerson M. Struik
Erasmus University Rotterdam
23 Papers
18 Citations
Gerson M. Struik is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 4, co-authored 12 publications.
Chat about Author
Papers
The prevalence of renal impairment among adults with early HIV disease in Blantyre, Malawi.
Gerson M. Struik,R.D. den Exter,C. Munthali,D. Chipeta,J.J. van Oosterhout,Jan L. Nouwen,Theresa J. Allain +6 more
TL;DR: It is concluded that renal impairment was common, though rarely severe, among HIV-infected adults with clinically non-advanced HIV disease, and relevant for ART programmes, such as those in Malawi, where renal function is not routinely assessed.
33
Randomized controlled trial comparing magnetic marker localization (MaMaLoc) with wire-guided localization in the treatment of early-stage breast cancer.
Gerson M. Struik,B. Schermers,B. Schermers,Ingeborg Mares,Harold E Lont,Jennifer W Bradshaw,Bernard ten Haken,Theo J.M. Ruers,Theo J.M. Ruers,Jurgen E M Mourik,Erwin Birnie,T.M.A.L. Klem +11 more
TL;DR: In this paper, the authors compared the use of a new magnetic marker localization (MaMaLoc) technique to WGL in the treatment of early-stage breast cancer patients, and reported higher overall satisfaction with MaMaLoc (median score 5/5) versus WGL (score 4/5).
15
Injection of radiopaque hydrogel at time of lumpectomy improves the target definition for adjuvant radiotherapy.
Gerson M. Struik,Nienke Hoekstra,T.M.A.L. Klem,Ali Ghandi,Gerda M. Verduijn,Annemarie T. Swaak-Kragten,Alja Schoonbeek,Kim C. de Vries,Margriet A. Sattler,Kees Verhoef,Erwin Birnie,Jean-Philippe Pignol,Jean-Philippe Pignol +12 more
TL;DR: The use of radiopaque PEG enables to identify the lumpectomy cavity, resulting in a high inter-observer agreement for radiotherapy target definition, and this intervention is easy to perform and blend well into current practice.
12
Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial
Elles M F van de Voort,Gerson M. Struik,Linetta B. Koppert,Adriaan Moelker,Reno Debets,Glenn Yo,Maura J P V Macco,R. Sinke,Martine Franckena,Erwin Birnie,Cornelis Verhoef,Taco M A L Klem +11 more
TL;DR: In this paper, a phase 2 screening trial was conducted to determine the efficacy rate of radiofrequency, microwave and cryoablation with the intention to select one treatment for further testing in a phase 3 trial.
10
Development and psychometric evaluation of a Dutch-translated shorter Breast Cancer Treatment Outcome Scale (Dutch BCTOS-13).
Gerson M. Struik,Frank W. de Jongh,Erwin Birnie,Jean Philippe Pignol,Jean Philippe Pignol,T.M.A.L. Klem +5 more
TL;DR: Good clinical validity makes the BCTOS-13 a useful tool to identify patients with unfavourable cosmetic and functional outcomes, requiring specific attention, andPsychometric evaluation of a newly developed Dutch BCTos-13 questionnaire in BCT patients showed excellent results.